#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	20492	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2572	965.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1726	1726	C	1267	C,T	1264,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	0	.	n	.	0	A412G	SNP	412	412	A	984	984	G	1291	G,A,T,C	641,629,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	0	.	n	.	0	T695C	SNP	695	695	T	1267	1267	C	1267	C,T,A,G	1260,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1909	1909	A	1398	A,G	1397,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2543	2543	C	1209	C,G	1206,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2617	2617	A	1158	A,G,C	1155,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35046	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4071	1072.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3169	3169	C	1268	C,G,A,T	1263,3,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2712	folP	855	855	100.0	folP.l15.c17.ctg.1	1933	174.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1216	1218	AGC	250;256;259	A,C;G,C;C	249,1;255,1;259	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6380	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3911	203.3	1	SNP	p	S91F	1	.	.	271	273	TTC	866	868	TTC	228;225;227	T;T,G,C;C	228;221,2,1;226	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6380	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3911	203.3	1	SNP	p	G95N	0	.	.	283	285	GGC	878	880	GGC	242;241;244	G;G,A;C	242;240,1;244	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6380	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3911	203.3	1	SNP	p	D95G	1	.	.	283	285	GGC	878	880	GGC	242;241;244	G;G,A;C	242;240,1;244	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2544	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1691	186.3	1	SNP	p	G45D	0	.	.	133	135	GGC	700	702	GGC	279;282;281	G,A;G;C	278,1;282;281	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1308	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	1609	101.4	0	.	n	.	0	A197.	DEL	197	197	A	836	836	A	267	A	267	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6440	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3625	221.4	1	SNP	p	D86N	0	.	.	256	258	GAC	935	937	GAC	287;289;290	G;A,T;C	286;288,1;290	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6440	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3625	221.4	1	SNP	p	R87I	0	.	.	259	261	CGT	938	940	CGT	289;289;289	C;G,A;T	289;288,1;289	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6440	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3625	221.4	1	SNP	p	R87W	0	.	.	259	261	CGT	938	940	CGT	289;289;289	C;G,A;T	289;288,1;289	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6440	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3625	221.4	1	SNP	p	S87R	1	.	.	259	261	CGT	938	940	CGT	289;289;289	C;G,A;T	289;288,1;289	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6440	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3625	221.4	1	SNP	p	S88P	0	.	.	262	264	TCC	941	943	TCC	288;288;289	T,G;C;C,T	287,1;288;287,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5608	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3120	223.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1733	1735	GGC	313;310;306	G,T,A;G,A,T;C	311,1,1;308,1,1;306	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1464	1466	GCA	314;316;317	G,A;C;A	313,1;316;317	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1467	1469	ATC	317;316;318	A;T;C	317;316;318	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1479	1481	GTG	325;327;329	G,A;T;G	324,1;327;329	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1479	1481	GTG	325;327;329	G,A;T;G	324,1;327;329	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1983	1985	ACC	319;320;321	A,C;C,G,T,A;C,G	317,2;316,2,1,1;320,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2037	2039	GCG	323;321;320	G;C,G;G,T	323;320,1;319,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2037	2039	GCG	323;321;320	G;C,G;G,T	323;320,1;319,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2160	2162	AGC	312;309;308	A,T;G;C,G,A	311,1;309;306,1,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2169	2171	GGC	311;308;306	G,C;G,T;C	310,1;307,1;306	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5444	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2767	244.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2187	2189	CCG	307;305;301	CCGC,CC;C,G;G	297,1;304,1;301	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7610	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3589	264.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1912	1914	CCG	300;301;298	C,A;C,A;G	299,1;300,1;298	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2968	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2203	167.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	791	791	C	212	C	212	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	30;36;37	T;T;A	30;36;37	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	68;68;68	C;A,C;T	68;67,1;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	68;68;68	A,G;G;T	67,1;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	68;68;68	T;A;C	68;68;68	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	1;1;1	T;C;G	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	1;1;1	A;G;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	226	90.27	porB1a.l15.c17.ctg.2	349	28.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	404	porB1a	984	93	95.7	porB1a.l15.c17.ctg.3	176	85.6	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	92;91;81	A;C;G	92;91;81	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	N38E	NONSYN	112	114	AAT	713	715	GAA	383;383;382	G;A;A,C	382;382;380,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1001	1003	GAT	322;323;325	G;A;T	322;323;325	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1124	1126	TCA	340;338;337	T;C;A	340;338;337	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	D212G	NONSYN	634	636	GAT	1235	1237	GGT	310;305;306	G;G,C;T	310;304,1;306	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1253	1255	GTC	282;277;278	G;T;C	282;277;278	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1265	1267	TCT	291;291;290	T,G;C;T	290,1;291;290	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1583	1585	GCA	321;318;320	G;C,T;A,T	321;317,1;319,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	1	SNP	p	G120K	1	.	.	358	360	AAG	959	961	AAG	302;303;305	A;A,G,T,C;G	302;300,1,1,1;305	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	1	SNP	p	A121D	1	.	.	361	363	GAC	962	964	GAC	305;307;309	G,T;A;C	303,1;307;309	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3904	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	2072	234.6	1	SNP	p	D121N	0	.	.	361	363	GAC	962	964	GAC	305;307;309	G,T;A;C	303,1;307;309	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13536	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	5420	311.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1908	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1411	167.8	1	SNP	p	V57M	1	.	.	169	171	ATG	731	733	ATG	318;316;314	A;T,A;G	318;315,1;314	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
